These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25135441)

  • 21. Electrospun polyurethane/Eudragit ® L100-55 composite mats for the pH dependent release of paclitaxel on duodenal stent cover application.
    Aguilar LE; Unnithan AR; Amarjargal A; Tiwari AP; Hong ST; Park CH; Kim CS
    Int J Pharm; 2015 Jan; 478(1):1-8. PubMed ID: 25445536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Paclitaxel-eluting stents in treatment of stenoses and chronic occlusions of coronary arteries].
    Maslov LN; Krylov AL
    Angiol Sosud Khir; 2007; 13(3):53-60. PubMed ID: 18382394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dexamethasone inhibits the effect of paclitaxel on human ovarian carcinoma xenografts in nude mice.
    Hou WJ; Guan JH; Dong Q; Han YH; Zhang R
    Eur Rev Med Pharmacol Sci; 2013 Nov; 17(21):2902-8. PubMed ID: 24254559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitinol stents loaded with a high dose of antitumor 5-fluorouracil or paclitaxel: esophageal tissue responses in a porcine model.
    Wang Z; Liu J; Wu K; Shen Y; Mao A; Li J; Chen Z; Guo S
    Gastrointest Endosc; 2015 Jul; 82(1):153-160.e1. PubMed ID: 25936448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.
    Yang W; Ge J; Liu H; Zhao K; Liu X; Qu X; Li W; Huang Y; Sun A; Zou Y
    Cardiovasc Res; 2006 Dec; 72(3):483-93. PubMed ID: 17020754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A polymer-free Paclitaxel eluting coronary stent: effects of solvents, drug concentrations and coating methods.
    Lamichhane S; Gallo A; Mani G
    Ann Biomed Eng; 2014 Jun; 42(6):1170-84. PubMed ID: 24705673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multilayered electrospun fibrous meshes for restenosis-suppressing metallic stents.
    Son YJ; Kim HS; Choi DH; Yoo HS
    J Biomed Mater Res B Appl Biomater; 2017 Apr; 105(3):628-635. PubMed ID: 26671717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multicenter randomized trial comparing amphilimus- with paclitaxel-eluting stents in de novo native coronary artery lesions.
    Carrié D; Berland J; Verheye S; Hauptmann KE; Vrolix M; Violini R; Dibie A; Berti S; Maupas E; Antoniucci D; Schofer J
    J Am Coll Cardiol; 2012 Apr; 59(15):1371-6. PubMed ID: 22284328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo characterization of a novel biocompatible polymer-lipid implant system for the sustained delivery of paclitaxel.
    Ho EA; Vassileva V; Allen C; Piquette-Miller M
    J Control Release; 2005 May; 104(1):181-91. PubMed ID: 15866344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel cathepsin B-sensitive paclitaxel conjugate: Higher water solubility, better efficacy and lower toxicity.
    Liang L; Lin SW; Dai W; Lu JK; Yang TY; Xiang Y; Zhang Y; Li RT; Zhang Q
    J Control Release; 2012 Jun; 160(3):618-29. PubMed ID: 22410114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A PTX/nitinol stent combination with temperature-responsive phase-change 1-hexadecanol for magnetocaloric drug delivery: Magnetocaloric drug release and esophagus tissue penetration.
    Jin Z; Wu K; Hou J; Yu K; Shen Y; Guo S
    Biomaterials; 2018 Jan; 153():49-58. PubMed ID: 29101815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: comparison with same drug-eluting overlapping stents.
    Kang WC; Oh KJ; Han SH; Ahn TH; Chung WJ; Shin MS; Koh KK; Choi IS; Shin EK
    Int J Cardiol; 2007 Dec; 123(1):12-7. PubMed ID: 17289176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy.
    Yoshizawa Y; Kono Y; Ogawara K; Kimura T; Higaki K
    Int J Pharm; 2011 Jun; 412(1-2):132-41. PubMed ID: 21507344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A heparin-rosuvastatin-loaded P(LLA-CL) nanofiber-covered stent inhibits inflammatory smooth-muscle cell viability to reduce in-stent stenosis and thrombosis.
    Liu Y; Liu P; Song Y; Li S; Shi Y; Quan K; Yu G; Li P; An Q; Zhu W
    J Nanobiotechnology; 2021 Apr; 19(1):123. PubMed ID: 33926468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A highly flexible paclitaxel-loaded poly(ε-caprolactone) electrospun fibrous-membrane-covered stent for benign cardia stricture.
    Zhu Y; Hu C; Li B; Yang H; Cheng Y; Cui W
    Acta Biomater; 2013 Sep; 9(9):8328-36. PubMed ID: 23770223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of uncovered stent with covered stent for treatment of malignant colorectal obstruction.
    Lee KM; Shin SJ; Hwang JC; Cheong JY; Yoo BM; Lee KJ; Hahm KB; Kim JH; Cho SW
    Gastrointest Endosc; 2007 Nov; 66(5):931-6. PubMed ID: 17767930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term evaluation of paclitaxel-coated stents for treatment of native coronary lesions. First results of both the clinical and angiographic 18 month follow-up of TAXUS I.
    Büllesfeld L; Gerckens U; Müller R; Grube E
    Z Kardiol; 2003 Oct; 92(10):825-32. PubMed ID: 14579046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials.
    Ohki T; Yokoi H; Kichikawa K; Kimura T; Snyder SA; Ragheb AO; O'Leary EE; Jaff MR; Ansel GM; Dake MD
    J Endovasc Ther; 2014 Oct; 21(5):644-53. PubMed ID: 25290792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions.
    Ray GM; Nawarskas JJ; Frishman WH
    Cardiol Rev; 2006; 14(3):143-50. PubMed ID: 16628023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.